Advertisement

Topics

iCell Therapeutics Inc Company Profile

15:08 EST 13th December 2018 | BioPortfolio

iCell Therapeutics is a dynamic biotechnology company dedicated to establishing new standards of care in oncology and cardiovascular treatments. iCell's proprietary site selective Low Density Emulsion (LDE) technology and products are backed by more than 16 years of research. The technology is validated by extensive pre-clinical animal and clinical studies. These studies have generated an array of new product candidates for cancer and cardiovascular diseases.

Location

Suite 203 1275 West 6th Ave
Vancouver
British Columbia
V6H 1A6
Canada

Contact

Phone: 1 (604) 221-7554
Email: info@icelltherapeutics.com


News Articles [704 Associated News Articles listed on BioPortfolio]

iCell Partners with LineaRx for new CAR-T Manufacturing Platform

iCell Gene Therapeutics, a New York-Zhongshan biopharma, has formed a research partnership for its CD19 CAR-T therapy with LineaRx, a subsidiary of Applied DNA Sciences. LineaRx is developing a non-vi...

Week in Review: Innovent's Hong Kong IPO: Raising $422 Million at $2 Billion Valuation

Deals and Financings  Innovent Biologics of Suzhou plans to raise $422 million at a $2 billion valuation in its Hong Kong IPO, scheduled for completion this month; HiFiBiO Therapeutics, a Boston...

iCell Gene Therapeutics Presents First-in-Human Data of CLL1-CD33 Compound CAR T in Refractory Acute Myeloid Leukemia

CLL1-CD33 Compound CAR (cCAR) demonstrates consistent, specific, and potent anti-tumor activity in vitro and in vivo cCAR possesses potential advantages ...

M&As this week: Nabriva Therapeutics, Sangamo Therapeutics, Ryboquin

Nabriva Therapeutics has completed the acquisition of Zavante Therapeutics for $97.5m. The acquisition will add the target company’s CONTEPO™ drug, which...Read More... The post M&As this we...

Roche’s Genentech agrees to buy Jecure Therapeutics

Based in San Diego of California, Jecure Therapeutics is engaged in the discovery of therapeutics to treat non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure Therapeutics president and CE...

HiFiBiO Therapeutics buys early-stage biotech firm H-Immune Therapeutics

The acquisition strengthens HiFiBiO Therapeutics’ strategic focus on identifying first-in-class targets for multiple immune cell types, as well as applying industry-leading technologies to develop d...

Cellular Dynamics International Inc Medical Equipment Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryCellular Dynamics International Inc CDI, a subsidiary of Fujifilm Holdings Corp is a biotechnology company that develops and manufactures fully functioning human cells in industrial quantities ...

Cellular Dynamics International Inc Medical Equipment Deals and Alliances Profile [Report Updated: 11052018] Prices from USD $250

SummaryCellular Dynamics International Inc CDI, a subsidiary of Fujifilm Holdings Corp is a biotechnology company that develops and manufactures fully functioning human cells in industrial quantities ...

PubMed Articles [460 Associated PubMed Articles listed on BioPortfolio]

COA-Cl induces dopamine release and tyrosine hydroxylase phosphorylation: In vivo reverse microdialysis and in vitro analysis.

We found that local perfusion of COA-Cl (0.1, 0.4, or 1.0 mM) into the dorsal striatum of living mice produced a significant and dose-dependent increase in extracellular DA levels, with the highest do...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Clinical Trials [164 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1286 Associated Companies listed on BioPortfolio]

iCell Therapeutics Inc

iCell Therapeutics is a dynamic biotechnology company dedicated to establishing new standards of care in oncology and cardiovascular treatments. iCell's proprietary site selective Low Density Emulsion...

iCell Gene Therapeutics, LLC

iCell Gene Therapeutics, located in Stony Brook, New York, is a clinical-stage biotechnology company developing first-in-class chimeric antigen receptor engineered cells. Clinical...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "iCell Therapeutics Inc" on BioPortfolio

We have published hundreds of iCell Therapeutics Inc news stories on BioPortfolio along with dozens of iCell Therapeutics Inc Clinical Trials and PubMed Articles about iCell Therapeutics Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of iCell Therapeutics Inc Companies in our database. You can also find out about relevant iCell Therapeutics Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record